It also reduces the risk of major cardiovascular events, such as heart attack, stroke, or death, in adults with type 2 diabetes and known heart disease, and decreases the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease
However, it should not be used by individuals with certain health conditions to ensure safety and effectiveness
61 GLP-1R activation triggers Gs-protein coupling, elevating cAMP, modulating calcium mobilization, and inducing -arrestin recruitment
Eur J Neurosci 57(1):148162 Daniele G, Iozzo P, Molina-Carrion M et al (2015) Exenatide regulates cerebral glucose metabolism in brain areas associated with glucose homeostasis and reward system
***Combined in- and out-of-network deductible, and out-of-pocket maximum Medical Plan Coverage Documents CareFirst provides a national network of providers so that you can get care right where you live